Maxim Feyaerts

Statistics

Publications

Citations

138

H-Index

Active since

2010

Affiliations

CEA Paris-Saclay - Etablissement de Fontenay-aux-roses(Current)

Maxim Feyaerts is an author at CEA Paris-Saclay - Etablissement de Fontenay-aux-roses specializing in antiretroviral therapy, pharmacology, and antiviral resistance.

Publications per year

2010–2014

Publications

Cross-Resistance Profile Determination of Two Second-Generation HIV-1 Integrase Inhibitors Using a Panel of Recombinant Viruses Derived from Raltegravir-Treated Clinical Isolates

Liesbeth Van Wesenbeeck, Evelien Rondelez, Maxim Feyaerts et al. · Antimicrobial Agents and Chemotherapy · 2010 · 53 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17

Pre-clinical development of a combination microbicide vaginal ring containing dapivirine and darunavir

Diarmaid J. Murphy, Delphine Desjardins, Nathalie Dereuddre‐Bosquet et al. · Journal of Antimicrobial Chemotherapy · 2014 · 42 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Resistance to raltegravir highlights integrase mutations at codon 148 in conferring cross-resistance to a second-generation HIV-1 integrase inhibitor

Olivia Goethals, Marcia Van Ginderen, Ann Vos et al. · Antiviral Research · 2011 · 32 citations

Life Sciences, Infectious Diseases, Molecular Genetics +14

Quantitative prediction of integrase inhibitor resistance from genotype through consensus linear regression modeling

Koen Van der Borght, Ann Verheyen, Maxim Feyaerts et al. · Virology Journal · 2013 · 11 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

1–4 of 4